Antihypertensive Medicine Use

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. Latvia Antihypertensive Medicine Use grew 12.5% in 2019, compared to a year earlier.
  2. Since 2014 Latvia Antihypertensive Medicine Use grew 7.7% year on year totalising 13.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day.
  3. In 2019 Hungary was number 1 in Antihypertensive Medicine Use.
  4. In 2019 Canada was ranked number 21 in Antihypertensive Medicine Use close to 3.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day, moving from 24 in 2018.

Top Countries in Antihypertensive Medicine Use

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Hungary
35 2019 +4.2 % +4.2 % View data
2 #2
Lithuania
24 2019 +4.7 % -3.6 % View data
3 #3
Slovakia
20 2019 +1.5 % -9.8 % View data
4 #4
Slovenia
15 2019 +0.7 % +0.0 % View data
5 #5
Latvia
14 2019 +12.5 % +7.7 % View data
6 #6
United Kingdom
13 2019 -0.7 % -0.7 % View data
7 #7
Germany
13 2019 +0.0 % -0.9 % View data
8 #8
Czech Republic
13 2019 +3.3 % -1.5 % View data
9 #9
Italy
10 2019 +0.0 % -1.2 % View data
10 #10
Spain
9 2019 +0.0 % +0.5 % View data
11 #11
Australia
8 2019 +1.2 % +1.3 % View data
12 #12
Austria
7 2019 -2.7 % -3.3 % View data
13 #13
Israel
7 2019 +1.6 % -0.9 % View data
14 #14
Belgium
6 2019 +1.6 % -0.6 % View data
15 #15
Greece
6 2019 +1.7 % +3.3 % View data
16 #16
Luxembourg
5 2019 -1.9 % +1.2 % View data
17 #17
Estonia
4 2019 -2.6 % -0.5 % View data
17 #17
Turkey
4 2019 +2.7 % +1.1 % View data
19 #19
Sweden
4 2019 -5.4 % +4.6 % View data
20 #20
Netherlands
3 2019 +0.0 % -0.6 % View data
21 #21
Canada
3 2019 +10.7 % +10.3 % View data
21 #21
Denmark
3 2019 +3.3 % +0.0 % View data
23 #23
Finland
3 2019 +0.0 % +0.7 % View data
24 #24
Iceland
3 2019 +7.4 % +4.8 % View data
25 #25
Chile
3 2019 +23.8 % +1.6 % View data
26 #26
Norway
3 2019 -21.9 % -9.4 % View data
27 #27
South Korea
2 2019 -5.3 % -4.8 % View data
28 #28
Portugal
1 2019 +0.0 % +0.0 % View data

Source: OECD

Go Top